Filtros de búsqueda

Lista de obras de Pau Riera

Comments on: "Clinical utility of ABCB1 genotyping for preventing toxicity in treatment with irinotecan"

artículo científico publicado en 2019

Gefitinib and afatinib show potential efficacy for Fanconi anemia-related head and neck cancer

artículo científico publicado en 2020

Genetic variants in the VEGF pathway as prognostic factors in stages II and III colon cancer.

artículo científico publicado en 2017

Novel Somatic Genetic Variants as Predictors of Resistance to EGFR-Targeted Therapies in Metastatic Colorectal Cancer Patients

artículo científico publicado en 2020

Pharmacogenetic clinical randomised phase II trial to evaluate the efficacy and safety of FOLFIRI with high-dose irinotecan (HD-FOLFIRI) in metastatic colorectal cancer patients according to their UGT1A 1 genotype

scientific article published on 26 December 2018

Physicochemical Compatibility of Amiodarone with Parenteral Nutrition

scientific article published on 10 July 2018

Physicochemical Compatibility of Dexmedetomidine With Parenteral Nutrition

scientific article published on 04 September 2019

Physicochemical Stability and Sterility of Standard Parenteral Nutrition Solutions and Simulated Y-Site Admixtures for Neonates.

artículo científico publicado en 2018

Prognostic effect of VEGF gene variants in metastatic non-small-cell lung cancer patients

scientific article published on 11 April 2019

Relevance of CYP3A4*20, UGT1A1*37 and UGT1A1*28 variants in irinotecan-induced severe toxicity.

artículo científico publicado en 2018

Relevance of the CYP3A4*20 variant as a predictor of paclitaxel-induced neuropathy in the Spanish population

artículo científico publicado en 2017

Role of IL6R Genetic Variants in Predicting Response to Tocilizumab in Patients with Rheumatoid Arthritis

artículo científico publicado en 2022

Targeted Next-Generation Sequencing in a Large Cohort of Genetically Undiagnosed Patients with Neuromuscular Disorders in Spain

scientific article published on 11 May 2020